Patient reported outcome measures in Waldenström macroglobulinaemia: A real‐world data analysis from the WMUK Rory Morrison Registry

Waldenström macroglobulinaemia (WM) is an incurable chronic B‐cell malignancy, but highly responsive to treatment. Treatments include fixed‐duration chemotherapy and continuous oral chemoimmunotherapy. In this expanding field, it is important to have reliable information on the impact of the various...

Descripción completa

Detalles Bibliográficos
Autores principales: Khwaja, Jahanzaib, Uppal, Encarl, Bristogiannis, Sotirios, McCarthy, Helen, Kothari, Jaimal, Rismani, Ali, Scorer, Harriet, Nicholson, Jane, El‐Sharkawi, Dima, D'Sa, Shirley, Kyriakou, Charalampia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928784/
https://www.ncbi.nlm.nih.gov/pubmed/36819170
http://dx.doi.org/10.1002/jha2.640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928784/
https://www.ncbi.nlm.nih.gov/pubmed/36819170
http://dx.doi.org/10.1002/jha2.640

Ejemplares similares